On May 17, 2019, the 20th anniversary of CellTrend took place. Numerous cooperation partners, customers and friends found their way to Luckenwalde on this day to celebrate with us. The audience was offered very interesting speeches by renowned scientists. Therefore we would like to thank Prof. Dr. med. Yehuda Shoenfeld (Sheba Medical Center, Tel Aviv),…
DetailsRead the abstract of this interesting article: Anti-angiotensin II type 1 receptor (AT1R) antibodies have been associated with allograft rejection. We hypothesized that circulating AT1R antibodies might identify kidney transplant recipients at increased risk of allograft rejection and loss who are not identified by the HLA system. We prospectively enrolled 1845 kidney transplant recipients from…
DetailsAbstract of the article: An autoimmune reaction directed against the cardiac b1-adrenergic receptor (beta1-ADR) leading to the generation of autoantibodies (AA) against this G-coupled receptor has been described in patients with heart failure (HF). Agonist-like beta1-ADR-AA are associated with morbidity in HF patients and even predict mortality. Standardised and valid diagnostic tools to detect beta…
DetailsThe 10th symposium for Clinical Environmental Medicine will take place in Kiel on 22.02.19 and 23.02.19. The topic is: “Exhaustion as a cardinal symptom of inflammatory and non-inflammatory diseases”. In addition to diagnostics, the focus will be on therapy. Flyer
DetailsAccording to the American Cancer Society ovarian cancer is expected to account for over 22,000 new cancer diagnoses and more than 14,000 deaths in 2018 in the US alone. In early stages of the disease, ovarian cancer is nearly asymptomatic. Hence, a large portion of the patients present with clinically advanced stages of ovarian cancer.…
DetailsBeta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More? Cardiovascular diseases are common, accounting for approximately 17.3 million global deaths annually. Substantial evidence exists for numerous risk factors including dyslipidemia, smoking, arterial hypertension, diabetes, and abdominal obesity. Numerous biomarkers have previously been reported in acute coronary syndromes, relating to both inflammation or…
DetailsThe POTS, CFS/ME, CRPS diagnostic takes place every 14 days in our lab. The next diagnostic will be on January, 23rd 2020. Please fill out the request form completely (important: email address and signature) and attach it to your shipment. Thank you very much!
DetailsHave a look at our latest publication in Nature Communication about autoantibodies against GPCR! 2018 Naturecommunication https://www.nature.com/articles/s41467-018-07598-9
DetailsVascular endothelial growth factor (VEGF) plays a central role in tumor growth, metastasis and angiogenesis. Various drugs (such as Avastin (R)) interfere tumor growth at this pathway. CellTrend were the first to describe auto-antibodies against VEGF and measures them with an validated ELISA. This discovery enables new strategies for personalization of tumor therapy and may…
DetailsCellTrends management system fullfills the requirement for the ISO 13485 standards.
